,outcome,arm 1,arm 2
0,intervention,active therapy,control group
0,N-telopeptide cross-linked collagen type I,decreased by 19.3 %,NR
0,"N-terminal propeptide of type I procollagen , a marker of bone formation",decreased by 26.6 %,NR
0,,NR,increases
